ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
AstraZeneca and the U.K. Medical Research Council Laboratory of Molecular Biology have established a joint fund to support drug discovery projects. AstraZeneca has committed up to $10 million and MRC up to $5 million over five years. The fund will support preclinical research projects conducted by AstraZeneca and MRC scientists. It’s the latest in a string of developments between AstraZeneca and MRC; earlier this year the partners announced plans to establish a joint research facility in AstraZeneca’s new Cambridge, England, R&D headquarters.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter